Eagle Bancorp, Inc.EGBNNASDAQ

|||

Overview News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Alerts

Want to monitor EGBN?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Create free account to monitor EGBN

Key Statistics

About

eaglebank is a local community business bank with 21 offices in maryland, northern virginia and washington, dc. the bank focuses on providing superior customer service and custom financial solutions for the local business community. eaglebank also offers a complete line of competitive personal banking products and services.

Sector

Finance and Insurance

Industry

Monetary Authorities-Central Bank

CEO

Susan Riel

eaglebankcorp.com/ →

News

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Klarna Group plc

newsfilecorp.com

Why investors shouldn't panic yet about Trump's credit-card rate-cap proposal

marketwatch.com

Exagen Inc. Announces Select Preliminary 2025 Financial Results

globenewswire.com

REGENXBIO Highlights Key 2026 Catalysts and Announces Positive Long-Term Functional Outcomes in Lead Duchenne Gene Therapy Program

prnewswire.com

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Gauzy

newsfilecorp.com

Pagaya Insider Sells $1.7 Million in Stock as Shares Significantly Outperform the Market

fool.com

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Freeport-McMoran

newsfilecorp.com

What Investors Should Know About a $186K OneStream Insider Stock Sale

fool.com

FRMI INVESTOR NOTICE: Fermi Inc. Investors with Substantial Losses Have Opportunity to Lead the Fermi Class Action Lawsuit

newsfilecorp.com

Google teams up with Walmart and other retailers to enable shopping within Gemini AI chatbot

techxplore.com

Is the Schwab U.S. Dividend Equity ETF a Buy Now?

fool.com

SoFi: Illogical Analyst Hate

seekingalpha.com

Stoke Therapeutics Announces Updates to Timelines for the Completion of Enrollment and a Phase 3 Data Readout from the EMPEROR Study of Zorevunersen for the Treatment of Dravet Syndrome

businesswire.com

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Firefly Aerospace

newsfilecorp.com

Should You Forget AGNC Investment and Buy Realty Income Instead?

fool.com

Dutch Bros: Could This Fast-Growing Coffee Chain Be a Long-Term Winner?

fool.com

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

Key Statistics

About

News

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Klarna Group plc

Why investors shouldn't panic yet about Trump's credit-card rate-cap proposal

Exagen Inc. Announces Select Preliminary 2025 Financial Results

REGENXBIO Highlights Key 2026 Catalysts and Announces Positive Long-Term Functional Outcomes in Lead Duchenne Gene Therapy Program

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Gauzy

Cogent Insider Sells $2.5 Million in Stock Amid Staggering 300% Price Surge

This CoreWeave Rival Could Double in 2026

3 Popular Stocks That Could Wipe Out a $100,000 Nest Egg

Which Vanguard Dividend ETF is a Better Buy: VYM or VIG?

Pagaya Insider Sells $1.7 Million in Stock as Shares Significantly Outperform the Market

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Freeport-McMoran

What Investors Should Know About a $186K OneStream Insider Stock Sale

FRMI INVESTOR NOTICE: Fermi Inc. Investors with Substantial Losses Have Opportunity to Lead the Fermi Class Action Lawsuit

Google teams up with Walmart and other retailers to enable shopping within Gemini AI chatbot

Is the Schwab U.S. Dividend Equity ETF a Buy Now?

SoFi: Illogical Analyst Hate

Stoke Therapeutics Announces Updates to Timelines for the Completion of Enrollment and a Phase 3 Data Readout from the EMPEROR Study of Zorevunersen for the Treatment of Dravet Syndrome

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Firefly Aerospace

Should You Forget AGNC Investment and Buy Realty Income Instead?

Dutch Bros: Could This Fast-Growing Coffee Chain Be a Long-Term Winner?​

Explore More

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Klarna Group plc

Why investors shouldn't panic yet about Trump's credit-card rate-cap proposal

Exagen Inc. Announces Select Preliminary 2025 Financial Results

REGENXBIO Highlights Key 2026 Catalysts and Announces Positive Long-Term Functional Outcomes in Lead Duchenne Gene Therapy Program

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Gauzy

Cogent Insider Sells $2.5 Million in Stock Amid Staggering 300% Price Surge

This CoreWeave Rival Could Double in 2026

3 Popular Stocks That Could Wipe Out a $100,000 Nest Egg

Which Vanguard Dividend ETF is a Better Buy: VYM or VIG?

Pagaya Insider Sells $1.7 Million in Stock as Shares Significantly Outperform the Market

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Freeport-McMoran

What Investors Should Know About a $186K OneStream Insider Stock Sale

FRMI INVESTOR NOTICE: Fermi Inc. Investors with Substantial Losses Have Opportunity to Lead the Fermi Class Action Lawsuit

Google teams up with Walmart and other retailers to enable shopping within Gemini AI chatbot

Is the Schwab U.S. Dividend Equity ETF a Buy Now?

SoFi: Illogical Analyst Hate

Stoke Therapeutics Announces Updates to Timelines for the Completion of Enrollment and a Phase 3 Data Readout from the EMPEROR Study of Zorevunersen for the Treatment of Dravet Syndrome

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Firefly Aerospace

Should You Forget AGNC Investment and Buy Realty Income Instead?

Dutch Bros: Could This Fast-Growing Coffee Chain Be a Long-Term Winner?​

Dutch Bros: Could This Fast-Growing Coffee Chain Be a Long-Term Winner?

Dutch Bros: Could This Fast-Growing Coffee Chain Be a Long-Term Winner?